 |
|
Inmate Access to Postrelease Medical Care: Public Health Implications
Abe M. Macher, MD
US Public Health Service Rockville, Md
Eric P. Goosby, MD
US Public Health Service Washington, DC
Arch Fam Med. 1997;6(4):318.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
In their 1994 study, Warren et al1 interviewed inmates who were seropositive for the human immunodeficiency virus (HIV) in a New York City correctional facility during their incarceration and after their release to determine accessibility to medical care services. The authors discovered that HIV-infected inmates were encountering considerable difficulties obtaining postrelease medical care in the community. Of 13 inmates who had been receiving isoniazid prophylaxis during their incarceration, only 1 was able to continue isoniazid prophylaxis after release into the community. The authors warned that such discontinuity of HIV care could potentially lead to active infectious tuberculosis in the community.1
Two years after their article was published, their prediction has become reality. In 1996, an HIV-infected inmate tested positive to a tuberculin purified protein derivative skin test. Because the results of his previous tuberculin purified protein derivative skin tests had all been negative, he was deemed
. . . [Full Text PDF of this Article]
|
